Carbamic acid, N-[(1S,2S)-1-[[(3S)-3,4-dihydro-7-[2-(hydroxyamino)-2-oxoethoxy]-3-[[(4-methoxyphenyl)amino]carbonyl]-2(1H)-isoquinolinyl]carbonyl]-2-methylbutyl]-, 1,1-dimethylethyl ester manufacturers
- ZYJ-25e
-
- $2500.00
-
2026-05-11
- CAS:1287261-04-4
- Purity:
- Supply Ability: 10g
|
| | Carbamic acid, N-[(1S,2S)-1-[[(3S)-3,4-dihydro-7-[2-(hydroxyamino)-2-oxoethoxy]-3-[[(4-methoxyphenyl)amino]carbonyl]-2(1H)-isoquinolinyl]carbonyl]-2-methylbutyl]-, 1,1-dimethylethyl ester Basic information |
| Product Name: | Carbamic acid, N-[(1S,2S)-1-[[(3S)-3,4-dihydro-7-[2-(hydroxyamino)-2-oxoethoxy]-3-[[(4-methoxyphenyl)amino]carbonyl]-2(1H)-isoquinolinyl]carbonyl]-2-methylbutyl]-, 1,1-dimethylethyl ester | | Synonyms: | Carbamic acid, N-[(1S,2S)-1-[[(3S)-3,4-dihydro-7-[2-(hydroxyamino)-2-oxoethoxy]-3-[[(4-methoxyphenyl)amino]carbonyl]-2(1H)-isoquinolinyl]carbonyl]-2-methylbutyl]-, 1,1-dimethylethyl ester;ZYJ 25e;ZYJ25e;ZYJ-25e | | CAS: | 1287261-04-4 | | MF: | C30H40N4O8 | | MW: | 584.66 | | EINECS: | | | Product Categories: | | | Mol File: | 1287261-04-4.mol | ![Carbamic acid, N-[(1S,2S)-1-[[(3S)-3,4-dihydro-7-[2-(hydroxyamino)-2-oxoethoxy]-3-[[(4-methoxyphenyl)amino]carbonyl]-2(1H)-isoquinolinyl]carbonyl]-2-methylbutyl]-, 1,1-dimethylethyl ester Structure](CAS/20210305/GIF/1287261-04-4.gif) |
| | Carbamic acid, N-[(1S,2S)-1-[[(3S)-3,4-dihydro-7-[2-(hydroxyamino)-2-oxoethoxy]-3-[[(4-methoxyphenyl)amino]carbonyl]-2(1H)-isoquinolinyl]carbonyl]-2-methylbutyl]-, 1,1-dimethylethyl ester Chemical Properties |
| density | 1.252±0.06 g/cm3(Predicted) | | pka | 9.13±0.20(Predicted) |
| | Carbamic acid, N-[(1S,2S)-1-[[(3S)-3,4-dihydro-7-[2-(hydroxyamino)-2-oxoethoxy]-3-[[(4-methoxyphenyl)amino]carbonyl]-2(1H)-isoquinolinyl]carbonyl]-2-methylbutyl]-, 1,1-dimethylethyl ester Usage And Synthesis |
| Description | ZYJ-25e is a histone deacetylase inhibitor (HDACi) with potent oral antitumor activities. | | Uses | ZYJ-25e is a potent histone deacetylase inhibitor (HDACi) with IC50s of 0.047 μM and 0.139 μM for HDAC6 and HDAC8, respectively. ZYJ-25e is a tetrahydroisoquinoline-bearing hydroxamic acid analogue. ZYJ-25e shows marked antitumor potency in the MDA-MB231 xenograft model[1]. | | IC 50 | HDAC6: 0.047 μM (IC50); HDAC8: 0.139 μM (IC50) | | References | [1] Yingjie Zhang, et al. Discovery of a tetrahydroisoquinoline-based hydroxamic acid derivative (ZYJ-34c) as histone deacetylase inhibitor with potent oral antitumor activities. J Med Chem. 2011 Aug 11;54(15):5532-9. DOI:10.1021/jm200577a |
| | Carbamic acid, N-[(1S,2S)-1-[[(3S)-3,4-dihydro-7-[2-(hydroxyamino)-2-oxoethoxy]-3-[[(4-methoxyphenyl)amino]carbonyl]-2(1H)-isoquinolinyl]carbonyl]-2-methylbutyl]-, 1,1-dimethylethyl ester Preparation Products And Raw materials |
|